151 related articles for article (PubMed ID: 12879777)
1. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J
Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
Zychma MJ; Gumprecht J; Strojek K; Grzeszczak W; Moczulski D; Trautsolt W; Karasek D
Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
[TBL] [Abstract][Full Text] [Related]
3. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
Meirhaeghe A; Helbecque N; Cottel D; Arveiler D; Ruidavets JB; Haas B; Ferrières J; Tauber JP; Bingham A; Amouyel P
Am J Med Genet; 2001 Jun; 101(1):4-8. PubMed ID: 11343328
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
Rafiq M; Flanagan SE; Patch AM; Shields BM; Ellard S; Hattersley AT;
Diabetes Care; 2008 Feb; 31(2):204-9. PubMed ID: 18025408
[TBL] [Abstract][Full Text] [Related]
5. ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.
Nikolac N; Simundic AM; Saracevic A; Katalinic D
Genet Test Mol Biomarkers; 2012 Aug; 16(8):924-30. PubMed ID: 22533711
[TBL] [Abstract][Full Text] [Related]
6. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
[TBL] [Abstract][Full Text] [Related]
7. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
Gloyn AL; Hashim Y; Ashcroft SJ; Ashfield R; Wiltshire S; Turner RC;
Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
[TBL] [Abstract][Full Text] [Related]
8. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
[TBL] [Abstract][Full Text] [Related]
9. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
Reis AF; Velho G
Diabetes Metab; 2002 Feb; 28(1):14-9. PubMed ID: 11938023
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O
Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
[TBL] [Abstract][Full Text] [Related]
12. The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):317-21. PubMed ID: 17516295
[TBL] [Abstract][Full Text] [Related]
13. [ATP-sensitive potassium channel--sulfonylurea receptor].
Yamada Y; Sunaga Y
Nihon Rinsho; 1997 Oct; 55 Suppl():458-62. PubMed ID: 9392149
[No Abstract] [Full Text] [Related]
14. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus.
Ishiyama-Shigemoto S; Yamada K; Yuan X; Koyama W; Nonaka K
Diabet Med; 1998 Oct; 15(10):826-9. PubMed ID: 9796882
[TBL] [Abstract][Full Text] [Related]
15. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients.
Dworacka M; Winiarska H; Jagodziński PP
Diabetes Res Clin Pract; 2007 Aug; 77(2):258-62. PubMed ID: 17207885
[TBL] [Abstract][Full Text] [Related]
16. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians.
Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
Hum Genet; 2000 Aug; 107(2):138-44. PubMed ID: 11030411
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.
Ohta Y; Tanizawa Y; Inoue H; Hosaka T; Ueda K; Matsutani A; Repunte VP; Yamada M; Kurachi Y; Bryan J; Aguilar-Bryan L; Permutt MA; Oka Y
Diabetes; 1998 Mar; 47(3):476-81. PubMed ID: 9519757
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between sulfonylurea receptor 1 gene polymorphism and type 2 diabetes mellitus].
Wang JS; Zhou L; Cheng JL; Shen MY
Yi Chuan; 2004 Jan; 26(1):8-12. PubMed ID: 15626659
[TBL] [Abstract][Full Text] [Related]
19. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
[TBL] [Abstract][Full Text] [Related]
20. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes.
Zhang H; Liu X; Kuang H; Yi R; Xing H
Diabetes Res Clin Pract; 2007 Jul; 77(1):58-61. PubMed ID: 17118480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
